Dana Investment Advisors’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.46M	Sell	26,379 -6,818	-21%	-$1.18M	0.13%	189
2025 Q4	$6.06M	Sell	33,197 -415	-1%	-$57.9K	0.18%	137
2025 Q3	$4.08M	Buy	33,612 +9,539	+40%	+$1.07M	0.12%	195
2025 Q2	$2.51M	Buy	24,073 +12,760	+113%	+$1.35M	0.08%	251
2025 Q1	$1.32M	Sell	11,313 -5,081	-31%	-$579K	0.05%	341
2024 Q4	$1.39M	Sell	16,394 -1,183	-7%	-$109K	0.05%	347
2024 Q3	$1.58M	Sell	17,577 -2,147	-11%	-$187K	0.05%	325
2024 Q2	$1.59M	Buy	19,724 +697	+4%	+$51.6K	0.05%	324
2024 Q1	$1.52M	Buy	19,027 +5,386	+39%	+$452K	0.05%	330
2023 Q4	$1.09M	Sell	13,641 -507	-4%	-$33.9K	0.05%	242
2023 Q3	$989K	Sell	14,148 -3,468	-20%	-$259K	0.05%	232
2023 Q2	$1.27M	Sell	17,616 -1,230	-7%	-$90.7K	0.06%	219
2023 Q1	$1.16M	Sell	18,846 -80	-0.4%	-$5.26K	0.06%	217
2022 Q4	$1.46M	Buy	18,926 +4,061	+27%	+$243K	0.08%	181
2022 Q3	$663K	Sell	14,865 -2,609	-15%	-$130K	0.04%	269
2022 Q2	$669K	Buy	17,474 +1,468	+9%	+$46.4K	0.03%	279
2022 Q1	$662K	Sell	16,006 -3,613	-18%	-$112K	0.03%	248
2021 Q4	$741K	Sell	19,619 -10,756	-35%	-$396K	0.03%	236
2021 Q3	$1M	Buy	30,375 +10,527	+53%	+$410K	0.05%	204
2021 Q2	$1.34M	Buy	19,848 +1,506	+8%	+$90.4K	0.06%	194
2021 Q1	$1.04M	Buy	+18,342	New	+$1.29M	0.05%	209